AIM
Price
$0.48
Change
+$0.04 (+9.09%)
Updated
Mar 28, 6:59 PM EST
4 days until earnings call
HOTH
Price
$1.52
Change
+$0.14 (+10.14%)
Updated
Mar 28, 6:59 PM EST
Ad is loading...

Analysis and predictions AIM vs HOTH

Header iconAIM vs HOTH Comparison
Open Charts AIM vs HOTHBanner chart's image
AIM ImmunoTech
Price$0.48
Change+$0.04 (+9.09%)
Volume$222.53K
CapitalizationN/A
Hoth Therapeutics
Price$1.52
Change+$0.14 (+10.14%)
Volume$170.06K
CapitalizationN/A
View a ticker or compare two or three
AIM vs HOTH Comparison Chart

Loading...

AIMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HOTHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AIM vs. HOTH commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Buy and HOTH is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (AIM: $0.47 vs. HOTH: $1.50)
Brand notoriety: AIM and HOTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 223% vs. HOTH: 44%
Market capitalization -- AIM: $23M vs. HOTH: $6.52M
AIM [@Biotechnology] is valued at $23M. HOTH’s [@Biotechnology] market capitalization is $6.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 0 FA rating(s) are green whileHOTH’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 0 green, 5 red.
  • HOTH’s FA Score: 1 green, 4 red.
According to our system of comparison, both AIM and HOTH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 5 TA indicator(s) are bullish while HOTH’s TA Score has 5 bullish TA indicator(s).

  • AIM’s TA Score: 5 bullish, 5 bearish.
  • HOTH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AIM and HOTH are a good buy in the short-term.

Price Growth

AIM (@Biotechnology) experienced а +23.62% price change this week, while HOTH (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

AIM is expected to report earnings on May 16, 2024.

HOTH is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AIM with price predictions.
OPEN
A.I.dvisor published
a Summary for HOTH with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AIM($23M) has a higher market cap than HOTH($6.52M). AIM YTD gains are higher at: 7.070 vs. HOTH (4.167). HOTH has higher annual earnings (EBITDA): -9.42M vs. AIM (-22.64M). AIM has more cash in the bank: 22.4M vs. HOTH (11.9M). AIM has higher revenues than HOTH: AIM (193K) vs HOTH (0).
AIMHOTHAIM / HOTH
Capitalization23M6.52M353%
EBITDA-22.64M-9.42M240%
Gain YTD7.0704.167170%
P/E RatioN/AN/A-
Revenue193K0-
Total Cash22.4M11.9M188%
Total Debt750KN/A-
FUNDAMENTALS RATINGS
AIM: Fundamental Ratings
AIM
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
5

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMHOTH
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
AIMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HOTHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZENV2.640.27
+11.60%
Zenvia
GSBC54.650.60
+1.11%
Great Southern Bancorp
BAP169.431.38
+0.82%
Credicorp Ltd
VJET0.64N/A
N/A
voxeljet AG
CORT25.21-0.11
-0.43%
Corcept Therapeutics

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with KALA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
+8.70%
KALA - HOTH
39%
Loosely correlated
-0.13%
TIL - HOTH
34%
Loosely correlated
-0.90%
AGE - HOTH
31%
Poorly correlated
N/A
AIM - HOTH
30%
Poorly correlated
+6.32%
OGEN - HOTH
28%
Poorly correlated
+2.86%
More